{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:42:30Z","timestamp":1786221750375,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pdpdt.2026.105543","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:37:46Z","timestamp":1781246266000},"page":"105543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of fingolimod therapy on choroidal vascularity index in patients with relapsing\u2013remitting multiple sclerosis: A retrospective longitudinal study"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8884-8676","authenticated-orcid":false,"given":"Ra\u015fit","family":"Dilek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-3627","authenticated-orcid":false,"given":"Ekim","family":"C\u00f6mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-6873","authenticated-orcid":false,"given":"Hamza","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105543_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primer."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0003","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0006","doi-asserted-by":"crossref","first-page":"47408","DOI":"10.1074\/jbc.M307687200","article-title":"Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases","volume":"278","author":"Billich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0007","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0008","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.52017","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review","volume":"11","author":"Coyle","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2011.05.005","article-title":"Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy","volume":"142","author":"Ingwersen","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0011","first-page":"1360","article-title":"Fingolimod: therapeutic mechanisms and ocular adverse effects","volume":"30","author":"Gupta","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/WNO.0b013e31829b42e1","article-title":"Fingolimod therapy and macular hemorrhage","volume":"33","author":"Bhatti","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0013","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/cells11060969","article-title":"Fingolimod (FTY720), a sphingosine-1-phosphate receptor agonist, mitigates choroidal endothelial proangiogenic properties and choroidal neovascularization","volume":"11","author":"Sorenson","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104775","article-title":"Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function","volume":"299","author":"Weigel","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ophtha.2012.07.048","article-title":"Subfoveal choroidal thickness: the Beijing Eye Study","volume":"120","author":"Wei","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0016","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1167\/iovs.11-8782","article-title":"Diurnal variation of choroidal thickness in normal subjects measured by spectral-domain OCT","volume":"53","author":"Tan","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bjophthalmol-2021-318782","article-title":"Choroidal vascularity index: a step towards software as a medical device","volume":"106","author":"Betzler","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0018","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","article-title":"Choroidal vascularity index in central serous chorioretinopathy","volume":"36","author":"Agrawal","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid in healthy eyes from a population-based study","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0020","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41433-022-02270-5","article-title":"Choroidal vascularity index and choroidal thickness: potential biomarkers in retinitis pigmentosa","volume":"37","author":"Abdolrahimzadeh","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40942-024-00607-8","article-title":"Choroidal vascularity index in health and systemic diseases: a systematic review","volume":"10","author":"Shariati","year":"2024","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.102823","article-title":"Analysis of choroidal vascularity index in multiple sclerosis patients without optic neuritis attack","volume":"38","author":"Temel","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1121899","article-title":"Microvascular impairments detected by optical coherence tomography angiography in multiple sclerosis patients: a systematic review and meta-analysis","volume":"16","author":"Liu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149138","article-title":"Repeatability using automatic tracing with Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000","volume":"11","author":"Brautaset","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamaophthalmol.2013.7288","article-title":"Characterization of the choroid-scleral junction and suprachoroidal layer in healthy individuals on enhanced-depth imaging optical coherence tomography","volume":"132","author":"Yiu","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0026","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1167\/iovs.14-14447","article-title":"Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images","volume":"55","author":"Sonoda","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0027","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ajo.2015.03.005","article-title":"Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images","volume":"159","author":"Sonoda","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0028","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0029","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0031","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/ijms21010109","article-title":"The inhibitory effects of gold nanoparticles on VEGF-A-induced cell migration in choroid-retina endothelial cells","volume":"21","author":"Chan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101389","article-title":"Unveiling the P2X7 receptor: exploring its mechanisms, pathogenic role in ocular diseases, and emerging therapeutic potential","volume":"105","author":"Chen","year":"2025","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0033","article-title":"What is the long-term efficacy and safety of selective laser trabeculoplasty in the management of primary open-angle glaucoma? A systematic review and meta-analysis","volume":"56","author":"Chen","year":"2025","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102786","article-title":"Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: reversing mitochondrial dysfunction and upregulating glyoxalase 1","volume":"64","author":"Sekar","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.pdpdt.2026.105543_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0036","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/ene.15612","article-title":"Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: new insights from the FREEDOMS II study","volume":"30","author":"Wang","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pdpdt.2026.105543_bib0037","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10792-018-0870-x","article-title":"Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing\u2013remitting multiple sclerosis","volume":"39","author":"Fruschelli","year":"2019","journal-title":"Int. Ophthalmol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026002103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026002103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:53:11Z","timestamp":1786218791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026002103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S1572100026002103"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105543","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of fingolimod therapy on choroidal vascularity index in patients with relapsing\u2013remitting multiple sclerosis: A retrospective longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105543"}}